0
Graft-versus-host disease (GVHD) is a complication that can occur after a stem cell or bone marrow transplant in which the newly transplanted material attacks the transplant recipient's body.
See also: Transplant rejection
Alternative NamesGVHD
Causes, incidence, and risk factorsGVHD occurs in a bone marrow or stem cell transplant involving a donor and a recipient. The bone marrow is the soft tissue inside bones that helps form blood cells, including white cells that are responsible for the immune response. Stem cells are normall found inside bone marrow.
Since only identical twins have identical tissue types, a donor's bone marrow is normally a close, but not perfect, match to the recipient's tissues. See: Histocompatibility antigen test
The differences between the donor's cells and recipient's tissues often cause T cells (a type of white blood cells) from the donor to recognize the recipient's body tissues as foreign. When this happens, the newly transplanted cells attack the transplant recipient's body.
Acute GVHD usually happens within the first 3 months after transplant. Chronic GVHD usually starts more than 3 months after transplant, and can last a lifetime.
Rates of GVHD vary from between 30 - 40% among related donors and recipients to 60 - 80% between unrelated donors and recipients. The greater the mismatch between donor and recipient, the greater the risk of GVHD. After a transplant, the recipient usually takes drugs that suppress the immune system, which helps reduce the chances (or severity) of GVHD.
SymptomsSymptoms in both acute and chronic GVHD range from mild to severe.
Common acute symptoms include:
- Abdominal pain or cramps
- Diarrhea
- Fever
- Jaundice
- Skin rash
- Vomiting
- Weight loss
Chronic symptoms may include:
In both acute and chronic GVHD, the patient is very vulnerable to infections.
Signs and testsThe tests done usually depend on the symptoms, but may include:
- Gastrointestinal endoscopy, with or without a biopsy
- Liver function tests (AST, ALP, and bilirubin levels will be increased)
- Liver biopsy(if the patient only has liver symptoms)
- Lung x-rays
- Skin biopsy
The goal of treatment is to suppress the immune response without damaging the new cells. Medicines commonly used include methotrexate, cyclosporine, tacrolimus, sirolimus, ATG, and alemtuzumab either alone or in combination.
High-dose corticosteroids are the most effective treatment for acute GVHD. Antibodies to T cells and other medicines are given to patients who do not respond to steroids.
Treatment of chronic GVHD includes prednisone (a steroid) with or without cyclosporine. Other treatments include mycophenolate mofetil (CellCept), sirolimus (Rapamycin), and tacrolimus (Prograf).
Expectations (prognosis)How well a person does depends on the severity of the condition. Some cases of GVHD can lead to death.
Many cases, whether acute or chronic, can be treated successfully. Sometimes treatment of the condition can lead to severe complications.
Successful treatment of GVHD does not guarantee that the transplant itself will succeed in treating the original disease.
Complications- Cholestasis
- Death
- Moderate to severe damage to the liver, lung, or digestive tract
- Severe infection
- Severe lung disease
If you have had a bone marrow or stem cell transplant, call your health care provider immediately if any unusual symptoms appear, including:
- Diarrhea
- Difficulty breathing
- Skin rash
- Stomach cramps
- Yellowing of the skin or eyes (jaundice)
Before a transplant, your blood type and tissue type will be carefully matched with eligible donors. This matching will reduce the risk of GVHD. Whenever possible, donations from closely matched family members can further decrease the risk of this problem. Absolute prevention of GVHD is not possible, and it is a risk when receiving a transplant from anyone else.
ReferencesHoffman R, Benz EJ, Shattil SS, et al, eds. Hematology: Basic Principles and Practice. 5th ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2008.
Sykes M. Transplantation immunology. In Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 46.
What else can I help you with?
What disease is Heart disease lung disease and diabetes considered?
Heart disease, lung disease and diabetes can all be considered organ diseases. Lung disease is a pulmonary disease, while heart disease is a cardiovascular disease. They are different.
What kind of disease is cardiac disease?
Cardiac disease is disease of the heart.
Does TI have a disease?
NO, T.I. does not have a disease they say he has a disease because he is very skinny but he does not have a disease.NO, T.I. does not have a disease they say he has a disease because he is very skinny but he does not have a disease.
What is a disease of affluence?
Heart disease is sometimes called a disease of affluence.
What is the disease of a heart?
Cardiac Disease, Heart disease.
Are Coronary artery disease and heart disease the same?
No; Coronary artery disease is a heart disease; or, CAD is one a disease that progresses into to Cardiomyopathy (heart disease) and MI. CAD is an aetiology of heart disease.
Is malaria an acute disease or chronic disease?
malaria is an acute disease
What is the difference between disease disease?
Every disease is an illness but not every illness is a disease (A disease is not a virus, parasite, etc but an illness could be)
What is the adjective of disease?
___________ disease - adjective the disease - noun to __________ - verb no answer
Is degenerative disease inherited disease or genetic disease?
inherited
Is huntington's disease dominate or recessive?
It is autosomal dominant, meaning it is not on a sex chromosome (X or Y). If one of your parents has the disease and they are heterozygote for the disease than there is a 50% chance of inheriting the disease yourself. If one of your parents has the disease and is homozygote for the disease (very unlikely!) then you will 100% inherit Huntington's Disease. If both of your parents have the disease and are both heterozygotes for the disease then there is a 75% chance that you will have the disease.
What are true statements about Huntington's Disease?
In the United States, about 1 in every 30,000 people has Huntington's Disease.
